Preparation and in vitro evaluation of 177Lu-iPSMA-RGD as a new heterobivalent radiopharmaceutical Academic Article uri icon

abstract

  • This study aimed to synthesize a new 177Lu-iPSMA-RGD heterobivalent radiopharmaceutical, as well as to assess the in vitro radiopharmaceutical potential to target cancer cells overexpressing PSMA and a(v) b(3) integrins. The radiotracer prepared with a ra

authors

  • DIAZ NIETO, LORENZA
  • ESCUDERO CASTELLANOS, ALONDRA
  • FERRO FLORES, GUILLERMINA
  • GARCIA BECERRA, ROCIO ANGELES
  • GARCIA QUIROZ, JANICE
  • Isaac Olivé Keila
  • OCAMPO GARCIA, BLANCA ELI
  • OLMOS ORTIZ, ANDREA GUADALUPE
  • SANTOS CUEVAS, CLARA LETICIA